Description | Genelux is a clinical-stage biopharmaceutical company evaluating a flexible and powerful therapeutic modality with the potential to redefine immuno-oncology. |
h1 tags | Your page doesn't have H1 tags. |
h2 tags | GENELUX REDEFINE RESET CHOICETM Why Oncolytic Immunotherapy? Our Approach The OLVI-VEC difference: |
Site Speed | 1.2377729415894 |
Alexa Rank: |
0 |
Site's Traffic |
Host | Type | Class | TTL | Target |
genelux.com | SOA | IN | 21600 | |
genelux.com | TXT | IN | 3600 | |
genelux.com | NS | IN | 21600 | ns1.dns.i2bnetworks.com |
genelux.com | NS | IN | 21600 | ns2.dns.i2bnetworks.com |
genelux.com | NS | IN | 21600 | ns3.dns.i2bnetworks.com |
genelux.com | MX | IN | 3600 | genelux-com.mail.protection.outlook.com |
genelux.com | A | IN | 21600 |